Upsher-Smith Laboratories announced it has received FDA approval for Qudexy XR (topiramate extended-release) capsules for the management of certain seizure disorders.
Pfizer has announced additional results from CAPiTA evaluating the efficacy of Prevnar 13 in preventing a first episode of vaccine-type community-acquired pneumonia in adults aged ≥65 years.
Mallinckrodt announced that the FDA has approved Xartemis XR (oxycodone HCl and acetaminophen) Extended-Release Tablets for the management of acute pain.
More than four million Americans have signed up for health coverage through state and federal insurance marketplaces established by the Affordable Care Act.
Proposed changes to the Medicare prescription drug program have been withdrawn by the Obama administration after strong opposition from patient groups.
For women undergoing surgery for vaginal prolapse and stress urinary incontinence, outcomes for two common transvaginal approaches are comparable, and perioperative behavioral therapy with pelvic floor muscle training does not improve surgical outcomes
An oral health screening tool helps identify children that need dental interventions during routine primary care visits.
Cefaly Technology has received FDA marketing approval for Cefaly, the first TENS device for the preventative treatment of migraine headaches.